GB1511645A – Sickle cell anaemia treatment
– Google Patents
GB1511645A – Sickle cell anaemia treatment
– Google Patents
Sickle cell anaemia treatment
Info
Publication number
GB1511645A
GB1511645A
GB15999/74A
GB1599974A
GB1511645A
GB 1511645 A
GB1511645 A
GB 1511645A
GB 15999/74 A
GB15999/74 A
GB 15999/74A
GB 1599974 A
GB1599974 A
GB 1599974A
GB 1511645 A
GB1511645 A
GB 1511645A
Authority
GB
United Kingdom
Prior art keywords
sickle cell
cell anaemia
treatment
methyl
anaemia treatment
Prior art date
1974-05-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB15999/74A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IFE, University of
Original Assignee
IFE, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1974-05-31
Filing date
1974-05-31
Publication date
1978-05-24
1974-05-31
Application filed by IFE, University of
filed
Critical
IFE, University of
1974-05-31
Priority to GB15999/74A
priority
Critical
patent/GB1511645A/en
1975-05-24
Priority to DE19752523108
priority
patent/DE2523108A1/en
1975-05-26
Priority to ZA00753364A
priority
patent/ZA753364B/en
1975-05-29
Priority to FR7516781A
priority
patent/FR2272647B1/fr
1975-05-29
Priority to NL7506384A
priority
patent/NL7506384A/en
1975-05-29
Priority to MW32/75A
priority
patent/MW3275A1/en
1975-05-30
Priority to BE156931A
priority
patent/BE829756A/en
1978-05-24
Publication of GB1511645A
publication
Critical
patent/GB1511645A/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
C07C59/40—Unsaturated compounds
C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
Abstract
1511645 Compositions for use in sickle cell anaemia treatment UNIVERSITY OF IFE 7 May 1975 [31 May 1974] 15999/74 Heading A5B Pharmaceutical compositions, for use in treating sickle cell anaemia, comprise a pharmaceutically acceptable vehicle and at least one antisickling agent of the formula: where R
GB15999/74A
1974-05-31
1974-05-31
Sickle cell anaemia treatment
Expired
GB1511645A
(en)
Priority Applications (7)
Application Number
Priority Date
Filing Date
Title
GB15999/74A
GB1511645A
(en)
1974-05-31
1974-05-31
Sickle cell anaemia treatment
DE19752523108
DE2523108A1
(en)
1974-05-31
1975-05-24
Remedies for sickle cell anemia
ZA00753364A
ZA753364B
(en)
1974-05-31
1975-05-26
Sickle cell anaemia treatment
FR7516781A
FR2272647B1
(en)
1974-05-31
1975-05-29
NL7506384A
NL7506384A
(en)
1974-05-31
1975-05-29
PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS FOR THE CONTROL OF SICKLE CELL ANAEMIA.
MW32/75A
MW3275A1
(en)
1974-05-31
1975-05-29
Sickle cell anaemia treatment
BE156931A
BE829756A
(en)
1974-05-31
1975-05-30
TREATMENT OF FALCIFORM HEMATIES ANEMIA
Applications Claiming Priority (1)
Application Number
Priority Date
Filing Date
Title
GB15999/74A
GB1511645A
(en)
1974-05-31
1974-05-31
Sickle cell anaemia treatment
Publications (1)
Publication Number
Publication Date
GB1511645A
true
GB1511645A
(en)
1978-05-24
Family
ID=10069370
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
GB15999/74A
Expired
GB1511645A
(en)
1974-05-31
1974-05-31
Sickle cell anaemia treatment
Country Status (7)
Country
Link
BE
(1)
BE829756A
(en)
DE
(1)
DE2523108A1
(en)
FR
(1)
FR2272647B1
(en)
GB
(1)
GB1511645A
(en)
MW
(1)
MW3275A1
(en)
NL
(1)
NL7506384A
(en)
ZA
(1)
ZA753364B
(en)
Cited By (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4410537A
(en)
1979-06-29
1983-10-18
Burroughts Wellcome Co.
Pharmaceutical ethers
US5635533A
(en)
*
1991-10-21
1997-06-03
The United States Of America As Represented By The Department Of Health And Human Services
Methods for inducing differentiation of a cell using phenyacetic acid and derivatives
US5843994A
(en)
*
1991-10-21
1998-12-01
The United States Of America As Represeneted By The Department Of Health And Human Services
Compositions and methods for treating and preventing pathologies including cancer
US5877213A
(en)
*
1991-10-21
1999-03-02
The United States Of America As Represented By The Department Of Health And Human Services
Compositions and methods for therapy and prevention of cancer, AIDS, and anemia
Families Citing this family (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
FR2550785B1
(en)
*
1983-08-18
1985-12-06
Sanofi Sa
NOVEL COMPOSITIONS WITH ANTIMICROBIAL ACTIVITY CONTAINING BENZOIC ACID DERIVATIVES, THEIR PREPARATION METHOD, THEIR USE AS DISINFECTANT OR PRESERVATIVE DRUGS
DE3886155T2
(en)
*
1987-09-25
1994-04-07
Zaidan Hojin Biseibutsu
Anthracycline derivatives with inhibitory activity against the reverse transcriptase of the human immunodeficiency virus.
EP0567613B1
(en)
*
1991-10-21
2002-02-20
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services
Compositions for therapy and prevention of cancer
1974
1974-05-31
GB
GB15999/74A
patent/GB1511645A/en
not_active
Expired
1975
1975-05-24
DE
DE19752523108
patent/DE2523108A1/en
not_active
Withdrawn
1975-05-26
ZA
ZA00753364A
patent/ZA753364B/en
unknown
1975-05-29
FR
FR7516781A
patent/FR2272647B1/fr
not_active
Expired
1975-05-29
MW
MW32/75A
patent/MW3275A1/en
unknown
1975-05-29
NL
NL7506384A
patent/NL7506384A/en
not_active
Application Discontinuation
1975-05-30
BE
BE156931A
patent/BE829756A/en
unknown
Cited By (12)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4410537A
(en)
1979-06-29
1983-10-18
Burroughts Wellcome Co.
Pharmaceutical ethers
US5635533A
(en)
*
1991-10-21
1997-06-03
The United States Of America As Represented By The Department Of Health And Human Services
Methods for inducing differentiation of a cell using phenyacetic acid and derivatives
US5635532A
(en)
*
1991-10-21
1997-06-03
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US5654333A
(en)
*
1991-10-21
1997-08-05
The United States Of America As Represented By The Department Of Health And Human Services
Methods for prevention of cancer using phenylacetic acids and derivatives thereof
US5661179A
(en)
*
1991-10-21
1997-08-26
The United States Of America As Represented By The Department Of Health And Human Services
Methods for treating neoplastic conditions using phenylacetic acid and derivatives thereof
US5708025A
(en)
*
1991-10-21
1998-01-13
The United States Of America As Represented By The Department Of Health And Human Services
Methods for promoting wound healing
US5712307A
(en)
*
1991-10-21
1998-01-27
The United States Of America As Represented By The Department Of Health And Human Services
Methods of inducing the production of hemoglobin and treating pathologies associated with abnormal hemoglobin activity using phemylacetic acids and derivatives therof
US5843994A
(en)
*
1991-10-21
1998-12-01
The United States Of America As Represeneted By The Department Of Health And Human Services
Compositions and methods for treating and preventing pathologies including cancer
US5852056A
(en)
*
1991-10-21
1998-12-22
The United States Of America As Represented By The Department Of Health And Human Services
Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
US5877213A
(en)
*
1991-10-21
1999-03-02
The United States Of America As Represented By The Department Of Health And Human Services
Compositions and methods for therapy and prevention of cancer, AIDS, and anemia
US5883124A
(en)
*
1991-10-21
1999-03-16
The United States Of America As Represented By The Department Of Health And Human Services
Compositions and methods for treating and preventing pathologies including cancer
US6037376A
(en)
*
1991-10-21
2000-03-14
The United States Of America As Represented By The Department Of Health And Human Services
Methods for therapy of cancer
Also Published As
Publication number
Publication date
NL7506384A
(en)
1975-12-02
FR2272647A1
(en)
1975-12-26
DE2523108A1
(en)
1975-12-18
ZA753364B
(en)
1976-05-26
FR2272647B1
(en)
1978-10-06
BE829756A
(en)
1975-09-15
MW3275A1
(en)
1976-09-08
Similar Documents
Publication
Publication Date
Title
MD1233B1
(en)
1999-05-31
Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
ES474592A1
(en)
1980-04-01
Imidazolidine derivatives, process for their preparation, intermediates for use in this process, pharmaceutical compositions containing them and the use of the active compounds.
KR910018398A
(en)
1991-11-30
Carbohydrate derivatives containing three saccharide units
GB1515284A
(en)
1978-06-21
Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
GB1205957A
(en)
1970-09-23
Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes
ES468181A1
(en)
1978-11-16
Antibiotics of the KA-6606 series and pharmaceutical compositions thereof
GB1473795A
(en)
1977-05-18
Nonapeptide amides having hormonal activity
ES8502709A1
(en)
1985-02-01
1-Alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them.
GB1511645A
(en)
1978-05-24
Sickle cell anaemia treatment
AU544923B2
(en)
1985-06-20
Peptides
GB1449397A
(en)
1976-09-15
Sunscreen composition
WO1987000174A3
(en)
1987-10-22
1-o-phosphono-saccharides, method for the production and utilization thereof
ES8106304A1
(en)
1981-06-16
7-Phenyl-quinolizidine derivatives (I), their preparation, pharmaceutical compositions containing them and (I) for use in treating diseases.
IE42168L
(en)
1976-04-18
1-alpha-hydroxy and alkanoyloxy-steroids
GB1274809A
(en)
1972-05-17
Evomonoside derivatives
GB1460163A
(en)
1976-12-31
Purification of 6,7-methylene steroid lactones
HU174882B
(en)
1980-04-28
Process for producing 1,12-methanooxymethano-indolo-square bracket-2,3-a-square bracket closed-quinolysine derivatives and pharmaceutical compositions containing them as active agents
JPS5473729A
(en)
1979-06-13
Novel muramyldipeptide derivative
ES485784A1
(en)
1980-05-16
Hydrocortisone esters, pharmaceutical compositions containing them and process for their preparation.
SE7710337L
(en)
1978-03-17
PROCEDURE FOR THE PREPARATION OF 9,11-HALOGENERATED STEROIDS
CA1027561A
(en)
1978-03-07
Pharmacologically active 1,4-benzodiazepins and process for their preparation
GB1504646A
(en)
1978-03-22
Acyl cyanoguanidines
HU174754B
(en)
1980-03-28
Process for producing 1,3-dihydro-spiro-bracket-isobenzo-furane-1,4-piperidine-bracket closed derivatives and pharmaceutical compositions containing them as active agents
GB1405135A
(en)
1975-09-03
Antileukaemic ansa macrolides
EG11806A
(en)
1977-11-30
Process for preparing of (1-imidazolyl-(1)-(2-4-4-chlorophenyl-phenoxy)-4,4-dimethylpentan-3-one and its salts,and their use as medicaments
Legal Events
Date
Code
Title
Description
1978-09-27
PS
Patent sealed
1990-01-04
PCNP
Patent ceased through non-payment of renewal fee
